A detailed history of Intrepid Family Office LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Intrepid Family Office LLC holds 20,000 shares of ROIV stock, worth $405,800. This represents 0.26% of its overall portfolio holdings.

Number of Shares
20,000
Holding current value
$405,800
% of portfolio
0.26%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$10.74 - $15.28 $214,800 - $305,600
20,000 New
20,000 $302,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $14.3B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Intrepid Family Office LLC Portfolio

Follow Intrepid Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrepid Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intrepid Family Office LLC with notifications on news.